{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:40Z","timestamp":1793731060374,"version":"4.6.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473460"],"award-info":[{"award-number":["82473460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303718"],"award-info":[{"award-number":["82303718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20250256"],"award-info":[{"award-number":["BX20250256"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ygeno.2025.111098","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:37:02Z","timestamp":1755013022000},"page":"111098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer"],"prefix":"10.1016","volume":"117","author":[{"given":"Xiaozhou","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parhat","family":"Kaysar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.ygeno.2025.111098_bb0005","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ygeno.2025.111098_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"22","key":"10.1016\/j.ygeno.2025.111098_bb0015","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1001\/jama.2020.21717","article-title":"Looking to Long-term survivors for improved pancreatic cancer treatment","volume":"324","author":"Kuehn","year":"2020","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","article-title":"Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.ygeno.2025.111098_bb0025","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ygeno.2025.111098_bb0030","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.7150\/thno.111180","article-title":"The TMBIM1-YBX1 axis orchestrates MDSC recruitment and immunosuppressive microenvironment in pancreatic cancer","volume":"15","author":"Tong","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41389-022-00411-9","article-title":"Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma","volume":"11","author":"Qian","year":"2022","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.ygeno.2025.111098_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1550341","article-title":"APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy","volume":"8","author":"Boichard","year":"2019","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12915-022-01316-0","article-title":"APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types","volume":"20","author":"Jakobsdottir","year":"2022","journal-title":"BMC Biol."},{"issue":"7920","key":"10.1016\/j.ygeno.2025.111098_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41586-022-04972-y","article-title":"Mechanisms of APOBEC3 mutagenesis in human cancer cells","volume":"607","author":"Petljak","year":"2022","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.ygeno.2025.111098_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh3083","article-title":"Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes","volume":"9","author":"Adler","year":"2023","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.ygeno.2025.111098_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122827","article-title":"APOBEC alteration contributes to tumor growth and immune escape in Pan-Cancer","volume":"14","author":"Guo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ygeno.2025.111098_bb0065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC enzymes: mutagenic fuel for Cancer evolution and heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111098_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020374","article-title":"APOBEC mutagenesis in cancer development and susceptibility","volume":"16","author":"Dananberg","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygeno.2025.111098_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-genet-072920-035840","article-title":"APOBEC-induced mutagenesis in cancer","volume":"56","author":"Mertz","year":"2022","journal-title":"Annu. Rev. Genet."},{"issue":"18","key":"10.1016\/j.ygeno.2025.111098_bb0080","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/s41388-018-0657-6","article-title":"APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma","volume":"38","author":"Cannataro","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13073-020-00781-y","article-title":"Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer","volume":"12","author":"Shi","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ygeno.2025.111098_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102905","article-title":"Molecular origins of APOBEC-associated mutations in cancer","volume":"94","author":"Petljak","year":"2020","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41588-023-01592-8","article-title":"The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance","volume":"56","author":"Caswell","year":"2024","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ygeno.2025.111098_bb0100","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.18632\/oncotarget.23344","article-title":"APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response","volume":"9","author":"Glaser","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ygeno.2025.111098_bb0105","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.7150\/thno.73235","article-title":"APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases","volume":"12","author":"Shi","year":"2022","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.ygeno.2025.111098_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21336","article-title":"Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma","volume":"9","author":"Luo","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ygeno.2025.111098_bb0115","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fonc.2019.01190","article-title":"Editorial: advances in the systemic therapy and combined modality approaches for head and neck cancer","volume":"9","author":"Argiris","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111098_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdy003","article-title":"Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution","volume":"29","author":"Venkatesan","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygeno.2025.111098_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108487","article-title":"Precision projections of the delay of resistance mutations in non-small cell lung cancer via suppression of APOBEC","volume":"202","author":"Nousias","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ygeno.2025.111098_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-cancerbio-050216-121919","article-title":"Stress-induced mutagenesis: implications in cancer and drug resistance","volume":"1","author":"Fitzgerald","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"6","key":"10.1016\/j.ygeno.2025.111098_bb0135","first-page":"895","article-title":"Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells","volume":"5","author":"Ubhi","year":"2024","journal-title":"Nat. Can."},{"issue":"6","key":"10.1016\/j.ygeno.2025.111098_bb0140","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1053\/j.gastro.2021.01.220","article-title":"Genomic features and classification of homologous recombination deficient pancreatic ductal adenocarcinoma","volume":"160","author":"Golan","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111098_bb0150","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ymthe.2025.01.023","article-title":"Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRAS(G12D) protein to cancer-associated fibroblasts","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ygeno.2025.111098_bb0155","article-title":"Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma","volume":"9","author":"Duan","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111098_bb0160","first-page":"1097","article-title":"Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer","volume":"1","author":"Steele","year":"2020","journal-title":"Nat. Can."},{"issue":"9","key":"10.1016\/j.ygeno.2025.111098_bb0165","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ygeno.2025.111098_bb0170","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/0008-5472.CAN-22-1508","article-title":"Estimation of neutral mutation rates and quantification of somatic variant selection using cancereffectsizeR","volume":"83","author":"Mandell","year":"2023","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ygeno.2025.111098_bb0175","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"7267","key":"10.1016\/j.ygeno.2025.111098_bb0180","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygeno.2025.111098_bb0185","first-page":"235","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Can."},{"issue":"Database issue","key":"10.1016\/j.ygeno.2025.111098_bb0190","first-page":"D955","article-title":"Genomics of drug sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ygeno.2025.111098_bb0195","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.ygeno.2025.111098_bb0200","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.ygeno.2025.111098_bb0205","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","article-title":"Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection","volume":"26","author":"Park","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ygeno.2025.111098_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063238","article-title":"Targeting DNA damage response and immune checkpoint for anticancer therapy","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ygeno.2025.111098_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msac084","article-title":"Attribution of Cancer origins to endogenous, exogenous, and preventable mutational processes","volume":"39","author":"Cannataro","year":"2022","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1878-0261.13721","article-title":"APOBEC3C-mediated NF-\u03baB activation enhances clear cell renal cell carcinoma progression","volume":"19","author":"Hase","year":"2025","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111098_bb0225","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/febs.16202","article-title":"APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites","volume":"289","author":"Constantin","year":"2022","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0230","doi-asserted-by":"crossref","first-page":"17725","DOI":"10.1038\/s41598-025-00169-1","article-title":"Characterization of RNA editing gene APOBEC3C as a candidate tumor suppressor in prostate cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ygeno.2025.111098_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081185","article-title":"Aberrant APOBEC3B expression in breast cancer is linked to proliferation and cell cycle phase","volume":"12","author":"Roelofs","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ygeno.2025.111098_bb0240","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41416-023-02239-5","article-title":"APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis","volume":"128","author":"Long","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.ygeno.2025.111098_bb0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41575-021-00463-z","article-title":"The pancreatic cancer genome revisited","volume":"18","author":"Hayashi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111098_bb0250","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41591-024-03362-3","article-title":"Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival","volume":"31","author":"Varghese","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41392-023-01446-z","article-title":"Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma","volume":"8","author":"Ling","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111098_bb0260","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/neuonc\/noab081","article-title":"Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas","volume":"23","author":"Yu","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"7973","key":"10.1016\/j.ygeno.2025.111098_bb0265","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","article-title":"Therapy-induced APOBEC3A drives evolution of persistent cancer cells","volume":"620","author":"Isozaki","year":"2023","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.ygeno.2025.111098_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn3815","article-title":"Concordance of hydrogen peroxide-induced 8-oxo-guanine patterns with two cancer mutation signatures of upper GI tract tumors","volume":"8","author":"Jin","year":"2022","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.ygeno.2025.111098_bb0275","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","article-title":"Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer","volume":"26","author":"Shakiba","year":"2025","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111098_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40265-024-02133-1","article-title":"Liposomal irinotecan: a review as first-line therapy in metastatic pancreatic adenocarcinoma","volume":"85","author":"Brown","year":"2025","journal-title":"Drugs"},{"issue":"20","key":"10.1016\/j.ygeno.2025.111098_bb0285","article-title":"Transcriptome landscape of cancer-associated fibroblasts in human PDAC","volume":"12","author":"Tao","year":"2025","journal-title":"Adv. Sci. (Weinh.)."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111098_bb0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12272-018-01108-7","article-title":"Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)","volume":"42","author":"Cho","year":"2019","journal-title":"Arch. Pharm. Res."}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754325001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754325001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:50:34Z","timestamp":1778694634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754325001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0888754325001144"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2025.111098","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2025.111098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111098"}}